Jonathan Brammer

This study is testing if a drug called ruxolitinib can help patients with T-cell lymphoma stay in remission after a stem cell transplant. The drug is taken daily for a year to try to prevent the cancer from coming back and to reduce a dangerous complication where the donor cells …

This study is testing whether a pill called ruxolitinib can help control a rare type of blood cancer called T-cell large granular lymphocyte leukemia (T-LGLL). The drug aims to shrink tumors and improve low blood counts by blocking signals that help the cancer cells grow. Researc…